Lowest Price Guaranteed
Pages
142
Last Updated
September 2025
View Count
13960
The global home healthcare market size is valued at USD 311.66 billion in 2024 and is projected to reach USD 719.31 billion by 2035, representing a CAGR of 7.90% during the forecast period.
A recent study published by World Health Organization stated that nearly 422 million people globally have diabetes, and the majority of these population belongs to low to middle income countries. Similarly, another report published by World Health Organization indicates that cardiovascular diseases are the most prevalent cause of premature death and disability in European region, causing more than 42.5% death annually.
This segment highlight the distribution of global market across various geographical regions such as North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America. Among these regions, North America currently accounts for the highest share (51%) of the market. Several factors that are contributing to the highest share of this region include the growing geriatric population with chronic conditions, advanced healthcare infrastructure and high disposable income. Furthermore, increasing government initiatives to support home healthcare is expected to be the key reason for the highest share of this region. In April 2024, The US FDA launched a strategic initiative (Home as a Healthcare Care Hub) with an aim of supporting the development of home-based healthcare solutions and home healthcare models.
 |
In Asia-Pacific, the market for home healthcare is expected to grow at a higher CAGR during the projected period. This substantial growth rate has been supported by the growing burden of patients with chronic conditions that require long term treatment and technological advancements for the development of innovative medical devices to facilitate remote care. It is worth mentioning that in June 2024, Star Health launched home healthcare services in more than 50 cities across India covering nursing care, lab diagnostics, medication and professional care to the patients.
The global home healthcare market size is categorized into different type of products such as therapeutic products (home respiratory therapy equipment, insulin delivery devices, home iv pumps, home dialysis equipment and others), diagnostic products (diabetic care unit, BP monitors, multi para diagnostic monitors, home pregnancy and fertility kits, apnea and sleep monitors, holter monitors, heart rate monitors and others) and mobility assisting products.
The products segment is likely to show lucrative growth potential and is expected to grow at a higher CAGR during the forecast period compared to services. This can be attributed to growing demand for advanced medical devices such as at-homecare testing kits, point-of-care diagnostics and drug delivery systems for disease diagnosis as well as management.
 |
 |
 |
Currently, services occupy an 85% share of the market with products accounting for the rest. Notably, home healthcare providers are offering a comprehensive range of services including nursing care, speech therapy, medication management and chronic disease management. This highest share is primarily attributed to the growing geriatric population with chronic conditions who require medical assistance for personal care and disease monitoring.
A number of home healthcare service providers have received funding in the recent past, to cater to the demand for personalized services as well. India based Lifetime Health received seed funding of $1.5 million in July 2024 to scale up their platform offering a range of services.
 |
 |
 |
Based on the disease indication, the global home healthcare market is segmented into cardiovascular disorders & hypertension, cancer, diabetes & kidney disorders, neurological disorders & mental disorders, respiratory diseases & chronic obstructive pulmonary diseases, maternal disorders, mobility disorders, wound care and other disease indications. It is worth highlighting here that cardiovascular disorders & hypertension currently occupies the highest share (26%) of the overall market. This dominance is due to the rising incidence of cardiovascular conditions across the globe that require continuous monitoring and instant medical support.
Furthermore, the shift towards unhealthy eating habits and sedentary lifestyle has resulted in hypertension or high blood pressure, which is considered as the most prevalent factor of heart attacks, stroke and other cardiological disorders. It is worth mentioning here that the growing awareness about early disease detection, monitoring and management of risk associated with cardiovascular disorders has bolstered the demand for home healthcare services.
In the long run, mobility disorders will grow at a higher CAGR during the forecast period. Mobility disorders refer to a condition that restrict physical movement followed by neurological impairment. According to the report of Centers for Disease Control and Prevention, mobility disability has been reported among 1 out of 7 adults and is common among middle-aged people and elderly population. This growing incidence of mobility issues has increased the demand for home healthcare services for daily task assistance and physiotherapies to regain mobility.
 |
 |
 |
The global market is categorized based on type of payors into public payors and private payors. Among these, public payors occupy the highest home healthcare market share, driven by the collaborative initiatives by health insurers to offer cost-effective healthcare services in countries such as Australia, United States, Germany and others.
Additionally, the increasing adoption of health insurance and improved medical care services have contributed to the growth in demand for home healthcare. However, in the long run, private payors will grow at a higher CAGR during the projected period driven by the growing number of private insurance payors who are offering health insurance for healthcare services.
Based on the type of distribution channel, the global home healthcare market is segmented into direct tenders and retail sales. Currently, direct tenders holds the highest share of the market driven by the growing preferences for remote monitoring devices for better homecare facility to manage disease condition. Furthermore, several home healthcare services providers have direct contact with the home healthcare product manufacturers.
However, in the future, retail sales will show lucrative growth potential and is expected to grow at a higher CAGR during the forecast period. This can be attributed to the growing shift towards patient-centric healthcare solutions and services. The retail sales involve direct sale of medical devices and products to different retail channels such as online platforms, pharmacies, specialty stores and other pharmacies. Furthermore, the growing aging population with chronic conditions has surged the demand for home-based care across the globe. These retail channels offer convenience and accessibility to home healthcare monitoring devices and drug delivery systems, which further contribute to the growth of this segment.
The “Global Home Healthcare Market: Industry Trends and Global Forecast, till 2035” market research report also features an in-depth analysis, highlighting the capabilities of various industry stakeholders engaged in this market. The market report highlights the efforts of several stakeholders engaged in this segment of the healthcare industry.
Currently, the market landscape is highly fragmented featuring the presence of several industrial players offering home healthcare products and services. Driven by the growing trends of home healthcare and remote patient monitoring, the key industrial leaders are promoting R&D activities for the development of advanced diagnosing kits, medical devices and encouraging healthcare experts to facilitate patient care in home settings. Several industrial leaders have launched digital therapeutics platforms and focus on the integration of AI technology with medical devices for real time data collection.
Furthermore, industrial stakeholders are taking strategic initiatives such as collaboration, partnership, and acquisition to make a strong foothold in the emerging market. Overall, the home healthcare market will remain competitive throughout the forecast period, offering enormous opportunities for industrial leaders to encourage active partnerships for technological advancements.
The market is experiencing significant growth, driven by several key factors. Firstly, the aging population globally is contributing to the expansion of this market. According to the World Health Organization (WHO), 1 in 6 people in the world will be 60 years and above, equating to around 1.4 billion people. Additionally, during the period 2000 – 2019, healthy life expectancy has increased by 5.4 years while total life expectancy has increased by 6.6 years. As such, the rise in elderly population along with increase in life expectancy will create a greater demand for home-based healthcare services, leading to home healthcare market growth.
The global market for home healthcare will also be propelled by increasing patient preferences for remote care and technological advancements. Patients with chronic diseases, specifically cardiovascular disorder, neurological disorder and respiratory diseases require long term treatment for managing disease conditions. Considering the long-term treatment demand, patients prefer home healthcare services and products that allow them to monitor disease progress and diagnose early signs to avoid emergencies.
Along with home healthcare trend, industry leaders are focusing on technological advancements including smart wearable devices, telemedicine and remote patient monitoring devices. These advanced devices allow real-time tracking of patient’s health condition, offering information to healthcare providers to address the potential issues that may need to be addressed promptly. Furthermore, wearable devices such as fitness trackers and smartwatches allow regular monitoring of vital health signs and provide valuable data to get treatment at earliest. These technological innovations have improved healthcare efficiency and enhanced patient compliance which further contributes to the home healthcare market growth.
Some of the potential challenges that may hinder market growth include complex regulatory guidelines and limited availability of skilled personnels. It is worth noting that smart remote monitoring devices require regulatory approval to ensure safety and effectiveness on human use. Each country has its own regulatory guidelines for home healthcare products and services. Hence, fragmented regulatory guidelines may create complications in the approval from the regulatory agencies.
In addition, high cost of home healthcare products and services may limit the widespread adoption, which may further impact market growth. Moreover, the limited availability of skilled personnel to offer home healthcare services may restrain market growth during the forecast period.
With the growing incidence of chronic conditions and rising awareness about complications with chronic diseases, the market leaders are focusing on preventive care. It is important to highlight here that preventive care and early diagnosis through home healthcare testing kits can reduce the requirement of patient readmission during emergencies. This growing emphasis on preventing care can further bolster the demand for advanced home healthcare solutions, which is anticipated to be a primary home healthcare market growth factor.
In addition, several industrial leaders are integrating artificial intelligence and Internet of Things to enhance patient monitoring and management of data. In July 2024, a startup company based in Trinity College Dublin, received funding of more than EUR 0.5 million for development of an AI based voice assistant to help patients with mobility disorders. Another startup Laennec AI Limited raised pre-seed funding for development of AI powered medical devices focused on home healthcare in November 2024.
Currently, North America is likely to remain dominant during the forecast period. North America has highest number of geriatric population with chronic conditions and neurological disorders. As per the recent report of Centers for Disease Control and Prevention, a quarter of the population in United States is expected to be over 65 years or older by 2060. Geriatric population is at greater risk of chronic conditions such as heart diseases, dementia, arthritis, type 2 diabetes and cancer.
In order to mitigate the concern of chronic conditions, healthcare industry are adopting home healthcare solutions including remote patient monitoring devices for disease monitoring and tracking. Several other factors that are contributing to the highest share of North America is high disposable income and advanced healthcare infrastructure.
Moreover, key players who are presently active in this domain are accelerating their development activities to launch new healthcare solutions and platforms that aid in disease diagnosis and monitoring at home. For Instance, in August 2024, Pfizer has launched direct-care navigation platform (PfizerForAll™) that helps patients with booking appointments, home delivery of medicines, along with other patient support services for prevention, treatment and testing of seasonal respiratory virus and migraines.
“People often experience information overload and encounter roadblocks when making decisions for themselves or their family in our complex and often overwhelming US healthcare system. This can be extremely time-consuming and lead to indecision or inaction—and as a result, poor health outcomes,” Aamir Malik, EVP and US chief commercial officer at Pfizer.
As more industrial players accelerate their efforts to support home healthcare, we believe the market in North America will continue to expand at a steady pace over the forecast period.
Examples of leading home healthcare companies (which have also been profiled in this market report; the complete list of companies is available in the full report) include 3M Healthcare, Abbott, Arkray, Acelity, Amedisys, Air Liquide, Addus Homecare, Atria Senior Living, BD, Bayer, B. Braun, Baxter International, Brookdale Senior Living Solutions, Cardinal Health, Drive DeVilbiss Healthcare, Diversicare Healthcare Services, Extendicare, Fresenius Kabi, GE Healthcare, Gentiva Health Services, Genesis Healthcare, Intersurgical, Johnson & Johnson, Kindred Healthcare, Linde Healthcare, Medtronic, Moog, Medline Industries, Medco Home Healthcare, NxStage Medical, Omron Healthcare, Roche, Sunrise Medical, Sunrise Carlisle, Senior Care Centers of America, Teleflex, and Vygon.
The market report presents an in-depth analysis of industrial leaders who are active across various segments as defined in the table below:
| Key Report Attributes | Details | |
| Historical Trend | Since 2019 | |
| Forecast Period | Till 2035 | |
| Market Size 2035 | $ 719.31 billion | |
| CAGR (Till 2035) | 7.90% | |
| Type of Product |
|
|
| Type of Service |
|
|
| Type of Disease Indication |
|
|
| Type of Payor |
|
|
| Type of Distribution Channel |
|
|
| Geographical Regions |
|
|
| Key Companies Profiled |
|
|
| PowerPoint Presentation (Complimentary) |
Available | |
| Customization Scope | 15% Free Customization | |
| Excel Data Packs (Complimentary) |
Available | |
One of the key objectives of the market report was to estimate the current home healthcare market size, opportunity and the market growth potential, over the forecast period, till 2035. We have provided informed estimates on the likely evolution of the market for the forecast period.
The home healthcare market analysis also features the likely distribution of the current and forecasted opportunity within the market across various segments, such as distribution by type of product, type of services, by disease indication, type of payor, type of distribution channel, geographical region and leading players.
In order to account for future uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base, and optimistic scenarios, representing different tracks of industry’s evolution.
All actual figures have been sourced from publicly available information forums and primary research discussions. The financial figures mentioned in this market report are in USD, unless otherwise specified.
Several recent developments have taken place in the market, some of which have been outlined below. These developments, even though they took place post the release of our market report, substantiate the overall market trends that we have outlined in our analyses.